18 Dec 2025 Confo Therapeutics Nominates SSTR5 Agonist Antibody CFTX-2034 as Development Candidate for Post-Bariatric Hypoglycemia Multiple categories
27 Oct 2025 Reclaiming the mind: How virtual reality helped one woman silence the voices in her head Multiple categories
07 Oct 2025 Biovia supports ALCOVE: early lung cancer detection through breath analysis Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
03 Oct 2025 New approach can drastically reduce antibiotic prescription for children Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
26 Aug 2025 Mynexuzhealth hits milestone: 1.5 million belgians now connected to their health records Multiple categories
25 Aug 2025 argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
